Dr. Nallamilli is a laboratory director of clinical molecular genetics at the Revvity Omics. Dr. Nallamilli specializes in clinical case sign-out, new test development and validations in the field of clinical molecular genetics with over 12 years of experience. His clinical research has focused on understanding the clinical and genetic basis of neuromuscular disorders including Duchenne muscular dystrophy and limb girdle muscular dystrophies. Dr. Nallamilli is also the lead R&D director of the clinical molecular genetics division at Revvity Omics.